Centene Corporation posts higher net earnings

Main growth drivers cited

Centene Corporation posts higher net earnings

Life & Health

By Terry Gangcuangco

Healthcare insurance provider Centene Corporation has released its results report for the third quarter of 2024 – a period marked by earnings growth.

Here’s how Centene performed in the quarter:

Metric

Q3 2024

Q3 2023

Premium and service revenues

$37 billion

$35 billion

Total revenues

$42 billion

$38 billion

Earnings from operations

$665 million

$735 million

Investment and other income

$432 million

$214 million

Net earnings

$710 million

$475 million

Net earnings attributable to Centene

$713 million

$469 million

 

The healthcare enterprise noted: “For the third quarter of 2024, premium and service revenues increased 6% to $36.9 billion from $35.0 billion in the comparable period of 2023. The increase was primarily driven by Medicaid rate increases and membership growth in the Marketplace business due to strong product positioning as well as overall market growth, partially offset by lower Medicaid membership primarily due to redeterminations and recent divestitures in the Other segment.

“Health benefits ratio of 89.2% for the third quarter of 2024 represents an increase from 87.0% in the comparable period in 2023. The increase was primarily driven by higher acuity in Medicaid resulting from the redetermination process as we continue to work with states to match rates with acuity. The increase was also driven by Medicare Star rating impacts.”

Meanwhile, according to chief executive Sarah M. London (pictured), Centene’s diversified portfolio allowed it to successfully navigate what she called a dynamic landscape in the quarter.

“At the same time, we delivered on fundamentals that carry positive implications for Centene’s multi-year earnings trajectory, including notable RFP wins, Medicare Stars improvements, and ongoing operational efficiencies,” London said.

“We remain confident in our full-year outlook for adjusted diluted EPS of greater than $6.80 and are well positioned to capture the powerful, long-term growth opportunities we see in government-sponsored healthcare.”

What do you think about this story? Share your thoughts in the comments below.

 

Related Stories

Keep up with the latest news and events

Join our mailing list, it’s free!